Biosimulation Market 2018- By Develop Strategies Based On the Latest Regulatory Events

Industry Trend Analysis

The biosimulation market is expected to be around $4 billion by 2025. This growth can be attributed to number of factors such as rise in incidence of chronic diseases such as diabetes, rise in aging population, high rate of drug resistance and failure. Moreover, unavailability of drugs to treat diseases such as AIDS and cancer is expected to further drive the global market. Further, rise in disposable income of the people and technological advancements such as use of micro assays for gene sequencing and analysis is set to contribute to the market growth. However, lack of standard method for biosimulation, lack of knowledge and unavailability of skilled professionals will restraint the market growth.

Product Outlook and Trend Analysis

Software segment accounted for the largest share of the global biosimulation market in 2016, as software being crucial component of the process. The onset of high end in silico software is expected to open up new pathway for improved personalized medicines and enable better disease care management through improved drug designing and medication.

Application Outlook and Trend Analysis

Drug development segment accounted for the largest share of the overall market in 2016 and is projected to witness robust growth during the forecast period, due to advancements in software for new drug development. The inclusion of high end software’s in drug designing will facilitate enhanced disease care through development of novel drugs especially in the field of personalized medicine.

End User Outlook and Trend Analysis

Pharmaceutical and biotechnology companies segment occupied major share of the global market in 2016 owing to rise in adoption rate of high end in silico software’s for developing new and advanced drugs for various diseases such as cancer and diabetes.

Regional Outlook and Trend Analysis

North America dominated the global market in 2016. This can be attributed to number of factors such as developed healthcare infrastructure, technological innovations such as development of biochips and advanced cell assay methods, and increase in number of patent files for many drugs and search for new drug entity. Asia-Pacific market is expected to grow at highest rate over the forecast period, owing to various factors such as increase disposable income of people, rapid healthcare infrastructure development and increasing need for integrating IT software in healthcare systems.

Competitive Analysis

Some of the major players in biosimulation market include Rhenovia Pharma Ltd., Dassault Systemes SA, Chemical Computing Group, Inc., Advanced Chemistry Development, Inc., Certara USA, Inc., Simulation Plus, Inc., Schrodinger, Inc., Entelos, Inc., Physiomics PLC, and Genedata AG. The major strategies adopted by them to sustain the market competition are increasing collaborations and partnerships, patient medication, mergers and acquisitions, drug repositioning, modeling and simulations in pediatrics drug development and new product launches. For instance, in December 2016, Chemical Computing Group, Inc. launched new version of its protein structure database system – PSILO 2016.10 with easy access to protein structural information leading to quick discovery of drugs.

Request Sample Copy: https://www.crystalmarketresearch.com/report-sample/HC0637 

Market Opportunities

There is a continuous rise in the demand for advanced software programs, which will provide ample growth opportunities for players operating in the global market. Technological advancements such as gene analysis, sequencing and coding, development of advanced mathematical model for biological assays and new methods of cell-based assays are expected to provide profitable market growth in coming years.

Biosimulation market is segmented as follows:

By Product:

  • Services
  • In-house Services
  • Contract Services
  • Software

By Application:

  • Drug Discovery
  • Drug Development
  • Others

By End User:

  • Regulatory Authorities
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutions
  • CROs

By Region:

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Turkey
  • United Arab Emirates
  • Others

Make an Enquiry at: https://www.crystalmarketresearch.com/send-an-enquiry/HC0637 

Table of Contents

1. Introduction

1.1. Report Description

1.2. Research Methodology

1.2.1. Secondary Research

1.2.2. Primary Research

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Share Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Rise in Incidence of Diabetes

3.3.1.2. Rise in Aging Population

3.3.1.3. High Rate of Drug Resistance

3.3.2. Restraints

3.3.2.1. Lack of Standard Method for Biosimulation

3.3.2.2. Lack of Knowledge and Unavailability of Skilled Professionals

3.3.3. Opportunities

3.3.3.1. Continuous Rise in Demand for Advanced Software Programs

3.3.3.2. Technological Advancements

3.4. Industry Trends

4. Biosimulation Market, By Product

4.1. Introduction

4.2. The Biosimulation Market Assessment and Forecast, By Product, 2016-2025

4.3. Services

4.3.1. Market Assessment and Forecast, By Type, 2016-2025 ($Million)

4.3.2. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.3.3. In-house Services

4.3.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.3.4. Contract Services

4.3.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

4.4. Services

4.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

5. Biosimulation Market, By Application

5.1. Introduction

5.2. Biosimulation Market Assessment and Forecast, By Application, 2016-2025

5.3. Drug Discovery

5.3.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

5.4. Drug Development

5.4.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

5.5. Others

5.5.1. Market Assessment and Forecast, By Region, 2016-2025 ($Million)

Get Discount: https://www.crystalmarketresearch.com/check-discount/HC0637 

About Crystal Market Research:

Crystal Market Research (CMR) is a main industry insight arrangement that gives all statistical surveying reports from top distributers, a U.S. based market research and business Intelligence Company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contacts Us: 
Judy | 304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
E-mail: sales@crystalmarketresearch.com | Tel: +1-888-213-4282
Web: www.crystalmarketresearch.com

%d bloggers like this: